ARID5A and neuroblastoma: Interestingly ARID5A was among these 30 de novo mutant genes unique to Met2, and a recent sequencing study has reported that mutations in the chromatin-remodeling genes ARID1A and ARID1B in neuroblastoma were associated with a more aggressive phenotype [16].